T cell anergy

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 305-334

  Schwartz, Ronald H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Adaptive tolerance; CD28 CTLA 4; Clonal anergy; IL 2 IL 2R; Regulatory T cells

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIGEN; CALCIUM; CD134 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 7; IONOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PD 90859; PHORBOL DIBUTYRATE; PROTEIN TYROSINE KINASE; RECEPTOR BLOCKING AGENT; ABATACEPT; ANTIBODY CONJUGATE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ANTIGEN;

CALCIUM MOBILIZATION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CLONAL ANERGY; COMPARATIVE STUDY; DOWN REGULATION; ENZYME ACTIVATION; GROWTH DISORDER; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; NONHUMAN; OBSERVATION; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE ACTIVATION; THYMUS; ADAPTATION; ADOPTIVE TRANSFER; ANIMAL; ANTIGEN PRESENTATION; BIOLOGICAL MODEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOLOGY; IMMUNOLOGY; METABOLISM; MOUSE; T LYMPHOCYTE;

ADAPTATION, PHYSIOLOGICAL; ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONAL ANERGY; HUMANS; IMMUNOCONJUGATES; INTERCELLULAR ADHESION MOLECULE-1; MICE; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 0042389785     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141110     Document Type: Review

References (123)

1. Von Pirquet CE. 1908. Das Verhalten der kutanen Tuberkulin-reaktion während der Masern. Münch. Med. Wochenschr. 34:1297-300
2. Nossal GJ, Pike BL. 1980. Clonal anergy: persistence in tolerant mice of antigenbinding B lymphocytes incapable of responding to antigen or mitogen. Proc. Natl. Acad. Sci. USA 77:1602-6
3. Schwartz RH, Mueller DL, Jenkins MK, Quill H. 1989. T-cell clonal anergy. Cold Spring Harbor Symp. Quant. Biol. 54(Part 2):605-10
4. Hargreaves RG, Borthwick NJ, Montani MS, Piccolella E, Carmichael P, et al. 1997. Dissociation of T cell anergy from apoptosis by blockade of Fas/Apo-1 (CD95) signaling. J. Immunol. 158:3099-107
5. Frauwirth KA, Alegre ML, Thompson CB. 2000. Induction of T cell anergy in the absence of CTLA-4/B7 interaction. J. Immunol. 164:2987-93
6. Mueller DL, Chiodetti L, Bacon PA, Schwartz RH. 1991. Clonal anergy blocks the response to IL-4, as well as the production of IL-2, in dual-producing T helper cell clones. J. Immunol. 147:4118-25
7. Perez VL, Van Parijs L, Biuckians A, Zheng XX, Strom TB, et al. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411-17
8. Schwartz RH. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1-8
9. Lechler R, Chai JG, Marelli-Berg F, Lombardi G. 2001. The contributions of T-cell anergy to peripheral T-cell tolerance. Immunology 103:262-69
10. Appleman LJ, Tzachanis D, Grader-Beck T, van Puijenbroek AA, Boussiotis VA. 2001. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics. J. Mol. Med. 78:673-83
11. + T cells induced by low avidity engagement of T cell receptor. J. Exp. Med. 194:719-31
12. Quill H, Schwartz RH. 1987. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J. Immunol. 138:3704-12
13. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. 2001. Type 1 T regulatory cells. Immunol. Rev. 182:68-79
14. Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldmann M. 1983. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 157:1434-47
15. Becker JC, Brabletz T, Kirchner T, Conrad CT, Brocker EB, et al. 1995. Negative transcriptional regulation in anergic T cells. Proc. Natl. Acad. Sci. USA 92:2375-78
16. Jenkins MK. 1992. The role of cell division in the induction of clonal anergy. Immunol. Today 13:69-73
17. Beverly B, Kang SM, Lenardo MJ, Schwartz RH. 1992. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4:661-71
18. Powell JD, Lerner CG, Schwartz RH. 1999. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J. Immunol. 162:2775-84
19. Wells AD, Walsh MC, Bluestone JA, Turka LA. 2001. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J. Clin. Invest. 108:895-903
20. Ragazzo IL, Ozaki ME, Karlsson L, Peterson PA, Webb SR. 2001. Costimulation via lymphocyte function-associated antigen 1 in the absence of CD28 ligation promotes anergy of naïve CD4+ T cells. Proc. Natl. Acad. Sci. USA 98:241-46
21. Holdorf AD, Lee KH, Burack WR, Allen PM, Shaw AS. 2002. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nat. Immunol. 3:259-64
22. Sagerstrom CG, Kerr EM, Allison JP, Davis MM. 1993. Activation and differentiation requirements of primary T cells in vitro. Proc. Natl. Acad. Sci. USA 90:8987-91
23. Hayashi RJ, Loh DY, Kanagawa O, Wang F. 1998. Differences between responses of naive and activated T cells to anergy induction. J. Immunol. 160:33-38
24. Lerner CG, Horton MR, Schwartz RH, Powell JD. 2000. Distinct requirements for C-C chemokine and IL-2 production by naive, previously activated, and anergic T cells. J. Immunol. 164:3996-4002
25. Chai JG, Lechler RI. 1997. Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4+ T cells in vitro. Int. Immunol. 9:935-44
26. Sepulveda H, Cerwenka A, Morgan T, Dutton RW. 1999. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. J. Immunol. 163:1133-42
27. Deleted in proof
28. Jenkins MK, Chen CA, Jung G, Mueller DL, Schwartz RH. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144:16-22
29. Jenkins MK, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH. 1987. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc. Natl. Acad. Sci. USA 84:5409-13
30. Macian F, Garcia-Cozar F, Im SH, Horton HF, Byrne MC, et al. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109:719-31
31. Mittelstadt PR, Ashwell JD. 1999. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells. J. Biol. Chem. 274:3222-27
32. Bowen F, Haluskey J, Quill H. 1995. Altered CD40 ligand induction in tolerant T lymphocytes. Eur. J. Immunol. 25:2830-34
33. + T cell clones expressing IL-3 receptor alpha-chains uses IL-3 as a cofactor in autocrine growth. J. Immunol. 153:3014-27
34. Sloan-Lancaster J, Evavold BD, Allen PM. 1994. Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180:1195-205
35. Telander DG, Malvey EN, Mueller DL. 1999. Evidence for repression of IL-2 gene activation in anergic T cells. J. Immunol. 162:1460-65
36. Kang SM, Beverly B, Tran AC, Brorson K, Schwartz RH, et al. 1992. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257:1134-38
37. Powell JD, Lerner CG, Ewoldt GR, Schwartz RH. 1999. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. J. Immunol. 163:6631-39
38. Mondino A, Whaley CD, DeSilva DR, Li W, Jenkins MK, et al. 1996. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells. J. Immunol. 157:2048-57
39. + T cells. Science 271:1272-76
40. Fields PE, Gajewski TF, Fitch FW. 1996. Blocked Ras activation in anergic CD4+ T cells. Science 271:1276-78
41. DeSilva DR, Jones EA, Feeser WS, Manos EJ, Scherle PA. 1997. The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells. Cell Immunol. 180:116-23
42. Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM. 1997. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rapl. Science 278:124-28
43. Sebzda E, Bracke M, Tugal T, Hogg N, Cantrell DA. 2002. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat. Immunol. 3:251-58
44. Quill H, Riley MP, Cho EA, Casnellie JE, Reed JC, et al. 1992. Anergic Th 1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn. J. Immunol. 149:2887-93
45. kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 6:290-97
46. Kipl. Eur. J. Immunol. 31:3737-46
47. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA. 1990. Stimulation of p21ras upon T-cell activation. Nature 346:719-23
48. Essery G, Feldmann M, Lamb JR. 1988. Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology 64:413-17
49. Boussiotis VA, Barber DL, Nakarai T, Freeman GJ, Gribben JG, et al. 1994. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science 266:1039-42
50. Boussiotis VA, Freeman GJ, Griffin JD, Gray GS, Gribben JG, et al. 1994. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J. Exp. Med. 180:1665-73
51. Bansal-Pakala P, Jember AG, Croft M. 2001. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat. Med. 7:907-12
52. Otten GR, Germain RN. 1991. Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science 251: 1228-31
53. Deeths MJ, Kedl RM, Mescher MF. 1999. CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. J. Immunol. 163:102-10
54. Tham EL, Shrikant P, Mescher MF. 2002. Activation-induced nonresponsiveness: a Th-dependent regulatory checkpoint in the CTL response. J. Immunol. 168:1190-97
55. Rammensee HG, Kroschewski R, Frangoulis B. 1989. Clonal anergy induced in mature V beta 6+ T lymphocytes on immunizing Mls-lb mice with Mls-la expressing cells. Nature 339:541-44
56. Rellahan BL, Jones LA, Kruisbeek AM, Fry AM, Matis LA. 1990. In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J. Exp. Med. 172:1091-100
57. + T cells in Staphylococcus enterotoxin B-primed mice. J. Exp. Med. 172:1065-70
58. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-13
59. Oxenius A, Zinkernagel RM, Hengartner H. 1998. Comparison of activation versus induction of unresponsiveness of virusspecific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity 9:449-57
60. Webb S, Morris C, Sprent J. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249-56
61. McCormack JE, Callahan JE, Kappler J, Marrack PC. 1993. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J. Immunol. 150:3785-92
62. Bandeira A, Mengel J, Burlen-Defranoux O, Coutinho A. 1991. Proliferative T cell anergy to Mls-la does not correlate with in vivo tolerance. Int. Immunol. 3:923-31
63. Kearney ER, Pape KA, Loh DY, Jenkins MK. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327-39
64. Rocha B, von Boehmer H. 1991. Peripheral selection of the T cell repertoire. Science 251:1225-28
65. Rocha B, Tanchot C, von Boehmer H. 1993. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. Exp. Med. 177:1517-21
66. Surh CD, Sprent J. 2000. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J. Exp. Med. 192:F9-14
67. Pape KA, Merica R, Mondino A, Khoruts A, Jenkins MK. 1998. Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160:4719-29
68. Rocha B, Grandien A, Freitas AA. 1995. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J. Exp. Med. 181:993-1003
69. Tanchot C, Barber DL, Chiodetti L, Schwartz RH. 2001. Adaptive tolerance of CD4+ T cells in vivo: multiple thresholds in response to a constant level of antigen presentation. J. Immunol. 167:2030-39
70. + T cells. J. Exp. Med. 185:405-14
71. Adler AJ, Huang CT, Yochum GS, Marsh DW, Pardoll DM. 2000. In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions. J. Immunol. 164:649-55
72. Grossman Z, Paul WE. 2001. Autoreactivity, dynamic tuning and selectivity. Curr. Opin. Immunol. 13:687-98
73. Ferber I, Schonrich G, Schenkel J, Mellor AL, Hammerling GJ, et al. 1994. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 263:674-76
74. Ramsdell F, Lantz T, Fowlkes BJ. 1989. A nondeletional mechanism of thymic self tolerance. Science 246:1038-41
75. Ramsdell F, Fowlkes BJ. 1992. Maintenance of in vivo tolerance by persistence of antigen. Science 257:1130-34
76. Burkly LC, Lo D, Flavell RA. 1990. Tolerance in transgenic mice expressing major histocompatibility molecules extrathymically on pancreatic cells. Science 248:1364-68
77. Hanahan D. 1998. Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr. Opin. Immunol. 10:656-62
78. Klein L, Kyewski B. 2000. Self-antigen presentation by thymic stromal cells: a subtle division of labor. Curr. Opin. Immunol. 12:179-86
79. Hoffmann MW, Heath WR, Ruschmeyer D, Miller JF. 1995. Deletion of highavidity T cells by thymic epithelium. Proc. Natl. Acad. Sci. USA 92:9851-55
80. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, von Boehmer H. 1988. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742-46
81. Carlow DA, Teh SJ, Teh HS. 1992. Altered thymocyte development resulting from expressing a deleting ligand on selecting thymic epithelium. J. Immunol. 148:2988-95
82. Robey EA, Ramsdell F, Gordon JW, Mamalaki C, Kioussis D, Youn HJ, Gottlieb PD, Axel R, Fowlkes BJ. 1992. A selfreactive T cell population that is not subject to negative selection. Int. Immunol. 4:969-74
83. Terrence K, Pavlovich CP, Matechak EO, Fowlkes BJ. 2000. Premature expression of T cell receptor (TCR) alpha beta suppresses TCR gamma delta gene rearrangement but permits development of gamma delta lineage T cells. J. Exp. Med. 192:537-48
84. Utting O, Teh SJ, Teh HS. 2000. A population of in vivo anergized T cells with a lower activation threshold for the induction of CD25 exhibit differential requirements in mobilization of intracellular calcium and mitogen-activated protein kinase activation. J. Immunol. 164:2881-89
85. Malvey EN, Jenkins MK, Mueller DL. 1998. Peripheral immune tolerance blocks clonal expansion but fails to prevent the differentiation of Th1 cells. J. Immunol. 161:2168-77
86. Greenwald RJ, Boussiotis VA, Lorsbach RB, Abbas AK, Sharpe AH. 2001. CTLA-4 regulates induction of anergy in vivo. Immunity 14:145-55
87. + T cell anergy in vivo. J. Immunol. 167:4936-41
88. Vanasek TL, Khoruts A, Zell T, Mueller DL. 2001. Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness. J. Immunol. 167:5636-44
89. Rogers PR, Song J, Gramaglia I, Killeen N, Croft M. 2001. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15:445-55
90. Bhandoola A, Cho EA, Yui K, Saragovi HU, Greene MI, Quill H. 1993. Reduced CD3-mediated protein tyrosine phosphorylation in anergic CD4+ and CD8+ T cells. J. Immunol. 151:2355-67
91. Goodnow CC. 1992. Transgenic mice and analysis of B-cell tolerance. Annu. Rev. Immunol. 10:489-518
92. Migita K, Eguchi K, Kawabe Y, Tsukada T, Ichinose Y, et al. 1995. Defective TCR-mediated signaling in anergic T cells. J. Immunol. 155:5083-87
93. Tanchot C, Guillaume S, Delon J, Bourgeois C, Franzke A, et al. 1998. Modifications of CD8+ T cell function during in vivo memory or tolerance induction. Immunity 8:581-90
94. Chau LA, Madrenas J. 1999. Phospho-LAT-independent activation of the rasmitogen-activated protein kinase pathway: a differential recruitment model of TCR partial agonist signaling. J. Immunol. 163:1853-58
95. Quill H, Riley MP, Cho EA, Casnellie JE, Reed JC, et al. 1992. Anergic Th 1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn. J. Immunol. 149:2887-93
96. + cells but negatively regulates their proliferative response to antigen stimulation. J. Immunol. 166:1540-46
97. Taniguchi T, Miyazaki T, Minami Y, Kawahara A, Fujii H, et al. 1995. IL-2 signaling involves recruitment and activation of multiple protein tyrosine kinases by the IL-2 receptor. Ann. NY Acad. Sci. 766:235-44
98. DeFranco AL, Yu C, Lowell CA. 2002. Autoimmunity and B cell tolerance in Lyndeficient mice. Presented at the Keystone Symp. Mechanisms and Applications of Immune Tolerance, Steamboat Springs, CO
99. Wotton D, Higgins JA, O'Hehir RE, Lamb JR, Lake RA. 1995. Differential induction of the NF-AT complex during restimulation and the induction of T-cell anergy. Hum. Immunol. 42:95-102
100. Taams LS, Wauben MH. 2000. Anergic T cells as active regulators of the immune response. Hum. Immunol. 61:633-39
101. Lombardi G, Sidhu S, Batchelor R, Lechler R. 1994. Anergic T cells as suppressor cells in vitro. Science 264:1587-89
102. + T cells. J. Exp. Med. 184:19-29
103. + T cells resulting in a failure to lyse tumor cells. Blood 93:1634-42
104. Boussiotis VA, Chen ZM, Zeller JC, Murphy WJ, Berezovskaya A, et al. 2001. Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease. Blood 97:565-71
105. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, et al. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-42
106. Cottrez F, Hurst SD, Coffman RL, Groux H. 2000. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 165:4848-53
107. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195:603-16
108. Faria AM, Weiner HL. 1999. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73:153-264
109. Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, et al. 1998. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 187:177-83
110. + T cells. Proc. Natl. Acad. Sci. USA 98:8738-43
111. Taams LS, van Rensen AJ, Poelen MC, van Els CA, Besseling AC, et al. 1998. Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur. J. Immunol. 28:2902-12
112. Taams LS, Boot EP, van Eden W, Wauben MH. 2000. 'Anergic' T cells modulate the T-cell activating capacity of antigen-presenting cells. J. Autoimmun. 14:335-41
113. Vendetti S, Chai JG, Dyson J, Simpson E, Lombardi G, et al. 2000. Anergic T cells inhibit the antigen-presenting function of dendritic cells. J. Immunol. 165:1175-81
114. + T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival. J. Immunol. 168:1060-68
115. Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, et al. 2002. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3:237-43
116. Shevach EM. 2002. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400
117. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18-32
118. Nishizuka Y, Sakakura T. 1969. Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166:753-55
119. Asano M, Toda M, Sakaguchi N, Sakaguchi S. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387-96
120. + T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol. 12:1145-55
121. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301-6
122. Waldmann H, Cobbold S. 2001. Regulating the immune response to transplants, a role for CD4+ regulatory cells? Immunity 14:399-406
123. + regulatory T cells prevent graft rejection: CTLA-4-and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168:1080-86